XML 67 R56.htm IDEA: XBRL DOCUMENT
v3.21.2

Acquisition-Related Amortization and Remeasurement - Additional Information (Details) - License Agreement [Member] $ in Millions | Apr. 07, 2021 USD ($)
--- | ---
Research And Development Arrangement Contract To Perform For Others [Line Items] |
Contingent Payment Upon Reaching FDA Milestone | $ 4.0
Amount Recieved In Second Quater | $ 0.5

X
- Definition Amount recieved in second quater + References No definition available. + Details
Name: | ofix_AmountRecievedInSecondQuater
Namespace Prefix: | ofix_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Contingent payment upon reaching fda milestone. + References No definition available. + Details
Name: | ofix_ContingentPaymentUponReachingFDAMilestone
Namespace Prefix: | ofix_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=us-gaap_LicenseAgreementTermsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |